• Craig M Coopersmith, Katherine C Chang, Paul E Swanson, Kevin W Tinsley, Paul E Stromberg, Timothy G Buchman, Irene E Karl, and Richard S Hotchkiss.
• Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA. coopersmithc@msnotes.wustl.edu
• Crit. Care Med. 2002 Jan 1; 30 (1): 195-201.

ObjectivesThe aim of this study was to determine whether decreasing intestinal epithelial apoptosis in sepsis would alter mortality rates. The roles of the antiapoptotic protein Bcl-2 and the "executioner" protease caspase-3 in sepsis-induced gut cell death also were evaluated.DesignProspective, randomized, controlled trial.SettingAnimal laboratory in an academic medical center.InterventionsTransgenic mice that overexpress Bcl-2 throughout the small intestinal epithelium (n = 23) and littermate controls (n = 27) were subjected to cecal ligation and puncture (CLP) and followed for 8 days to assess survival. A second group of transgenic (n = 15) and littermate animals (n = 15) were subjected to CLP and were killed between 16 and 48 hrs postoperatively to assess for intestinal apoptosis and active caspase-3 staining.Measurements And Main ResultsSurvival of transgenic animals was 83% 8 days after CLP compared with 44% for littermate controls (p < .005). Survival curves between the two groups of animals began diverging within 24 hrs. Overexpression of Bcl-2 was associated with a significant decrease in apoptosis between 16 and 24 hrs post-CLP (p < .05) as well as decreased staining for active caspase-3.ConclusionsDecreasing intestinal epithelial cell death via overexpression of Bcl-2 improves survival in septic mice. The gut may play a central role in the pathophysiology of sepsis.

14 keywords...

hide…